Business and Technology News

Business, Life Sciences, and Technology News

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn’t the same as a human. But Horn, a veterinarian, says there are enough similarities between the species to take the science behind biological drugs for people and apply it to animals. […]

Join Xconomy on April 29 at Takeda Pharmaceuticals’ Boston location for the next in our Xcelerating Life Sciences event series: Biopharma’s Future in Digital Health. The half-day conference will bring together innovators, executives, rising pioneers, entrepreneurs, investors, and scientists to examine what’s fueling Boston’s biotech investment and partnership opportunities. As the nation’s largest biopharma cluster, […]

Three months after resTORbio’s lead drug failed a pivotal test treating lung infections in the elderly, the company is now looking for someone to buy the firm or strike a deal for its technology. In a corporate update issued Wednesday, resTORbio (NASDAQ: TORC) says it has started a process to evaluate “partnerships, acquisitions, mergers, and […]

Ligand Pharmaceuticals is adding neurological disease and cystic fibrosis programs to its pipeline through a deal to acquire assets from drug discovery company Icagen. San Diego-based Ligand (NASDAQ: LGND) is paying $15 million up front for the “core assets” of Icagen’s Durham, NC operations. The neuroscience program is being developed under a partnership with Roche […]

The FDA has placed a clinical hold on a LogicBio Therapeutics application to begin human testing of its experimental gene-editing therapy for a rare, inherited liver disorder. LogicBio (NASDAQ: LOGC) disclosed the clinical hold for its gene-editing therapy, LB-001, after Monday’s market close. The Cambridge, MA-based biotech said that the hold concerns “certain clinical and […]

Section Page news and features from Crain's New York Business

Jurors at Harvey Weinstein’s New York City are set to Monday after signaling they are at odds on the top charges in the closely watched #MeToo case.The jury sent a note to Judge James Burke at...

To view the full story, click the title link.

To view the full story, click the title link.

Jurors at Harvey Weinstein’s New York City are set to Monday after signaling they are at odds on the top charges in the closely watched #MeToo case.The jury sent a note to Judge James Burke at...

To view the full story, click the title link.

To view the full story, click the title link.

Jurors at Harvey Weinstein’s New York City are set to Monday after signaling they are at odds on the top charges in the closely watched #MeToo case.The jury sent a note to Judge James Burke at...

To view the full story, click the title link.

Jurors at Harvey Weinstein’s New York City are set to Monday after signaling they are at odds on the top charges in the closely watched #MeToo case.The jury sent a note to Judge James Burke at...

To view the full story, click the title link.

The move could hamstring the Chinese tech giant if it prevents the firm’s customers from getting the latest versions of services such as Maps and Gmail.

Shareholders are voting on whether to push the tech giant to examine the human rights and financial risks of the surveillance technology.

Artificial intelligence may help doctors make more accurate readings of CT scans used to screen for lung cancer.

The great hope for people without a bachelor’s degree hasn’t yet spread beyond small-scale success stories.

When it comes to disinformation, all signs suggest the 2020 presidential campaign will make 2016 look like a mere test run, our columnist writes.

The price was relatively small, but the deal may have a big impact on the race between the United States and China to build more powerful computers.